| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cyclin-dependent kinase 5 activator 1 |
|---|
| Ligand | BDBM50229962 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_473638 (CHEMBL937655) |
|---|
| IC50 | >100000±n/a nM |
|---|
| Citation |  Fedorov, O; Marsden, B; Pogacic, V; Rellos, P; Müller, S; Bullock, AN; Schwaller, J; Sundström, M; Knapp, S A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A104:20523-8 (2007) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cyclin-dependent kinase 5 activator 1 |
|---|
| Name: | Cyclin-dependent kinase 5 activator 1 |
|---|
| Synonyms: | CD5R1_HUMAN | CDK5R | CDK5R1 | Cyclin-Dependent Kinase 5 Activator 1, p35 | Cyclin-dependent kinase 5 (CDK5/p25) | Cyclin-dependent kinase 5 regulatory subunit 1 | NCK5A | TPKII regulatory subunit | p35 |
|---|
| Type: | Enzyme Subunit |
|---|
| Mol. Mass.: | 34077.43 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q15078 |
|---|
| Residue: | 307 |
|---|
| Sequence: | MGTVLSLSPSYRKATLFEDGAATVGHYTAVQNSKNAKDKNLKRHSIISVLPWKRIVAVSA
KKKNSKKVQPNSSYQNNITHLNNENLKKSLSCANLSTFAQPPPAQPPAPPASQLSGSQTG
GSSSVKKAPHPAVTSAGTPKRVIVQASTSELLRCLGEFLCRRCYRLKHLSPTDPVLWLRS
VDRSLLLQGWQDQGFITPANVVFLYMLCRDVISSEVGSDHELQAVLLTCLYLSYSYMGNE
ISYPLKPFLVESCKEAFWDRCLSVINLMSSKMLQINADPHYFTQVFSDLKNESGQEDKKR
LLLGLDR
|
|
|
|---|
| BDBM50229962 |
|---|
| n/a |
|---|
| Name | BDBM50229962 |
|---|
| Synonyms: | 1-(4-methoxybenzyl)-3-(5-nitrothiazol-2-yl)urea | AR-A014418 | CHEMBL259850 | N-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C12H12N4O4S |
|---|
| Mol. Mass. | 308.313 |
|---|
| SMILES | COc1ccc(CNC(=O)Nc2ncc(s2)[N+]([O-])=O)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
